tiprankstipranks
Kriti Nutrients Limited (IN:KRITINUT)
:KRITINUT
India Market

Kriti Nutrients Limited (KRITINUT) AI Stock Analysis

0 Followers

Top Page

IN:KRITINUT

Kriti Nutrients Limited

(KRITINUT)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 5.2)
Rating:63Neutral
Price Target:
₹65.00
▼(-17.30% Downside)
Action:ReiteratedDate:03/31/26
The score is driven mainly by solid underlying financial performance (especially a very strong balance sheet) and an attractive low P/E, but it is held back by weakening margins/cash flow and notably bearish technical signals (price below major moving averages with negative MACD).
Positive Factors
Strong balance sheet
Kriti's minimal financial leverage and high equity backing provide durable financial flexibility. A D/E of 0.01 and strong equity ratio reduce refinancing and liquidity risk, allowing the company to fund working capital, weather commodity cycles, and support operations over the next 2–6 months.
Negative Factors
Falling net margins
A material decline in net margin signifies rising costs or weakening pricing power. Lower net profitability reduces retained earnings available for reinvestment or buffers, making the company more vulnerable to further margin compression from input cost spikes or weaker end-market pricing.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet
Kriti's minimal financial leverage and high equity backing provide durable financial flexibility. A D/E of 0.01 and strong equity ratio reduce refinancing and liquidity risk, allowing the company to fund working capital, weather commodity cycles, and support operations over the next 2–6 months.
Read all positive factors

Kriti Nutrients Limited (KRITINUT) vs. iShares MSCI India ETF (INDA)

Kriti Nutrients Limited Business Overview & Revenue Model

Company Description
Kriti Nutrients Limited engages in the manufacture and sale of soyabean seeds under the Kriti brand in India and internationally. It offers edible oils, such as refined sunflower oil, soya bean oil, filtered groundnut oil, and mustard oil; soya le...
How the Company Makes Money
Kriti Nutrients Limited makes money primarily by processing oilseeds (notably soybeans) and selling the resulting products across the edible oil and soy-products value chain. Key revenue streams generally include: (1) Sale of edible oils (such as ...

Kriti Nutrients Limited Financial Statement Overview

Summary
Financials are solid overall: revenue grew 7.47% (2024 to 2025) and the balance sheet is very strong with minimal leverage (debt-to-equity 0.01) and healthy ROE (17.46%). Offsetting this, net margin fell to 5.03% (from 6.63%) and free cash flow weakened, pointing to profitability and cash generation pressure.
Income Statement
72
Positive
Balance Sheet
78
Positive
Cash Flow
65
Positive
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue8.15B7.34B6.83B7.96B7.51B6.90B
Gross Profit890.11M1.03B1.07B780.37M679.84M378.97M
EBITDA486.40M557.89M666.67M356.28M222.83M242.58M
Net Income315.50M369.94M452.87M207.98M123.05M150.57M
Balance Sheet
Total Assets2.56B2.38B2.09B1.93B1.68B1.24B
Cash, Cash Equivalents and Short-Term Investments521.26M265.85M210.43M190.38M37.16M30.21M
Total Debt59.08M30.69M121.45M403.73M375.58M35.38M
Total Liabilities271.89M259.39M325.25M607.00M554.76M232.38M
Stockholders Equity2.29B2.12B1.76B1.32B1.13B1.01B
Cash Flow
Free Cash Flow397.30M273.10M409.62M133.43M-193.72M38.16M
Operating Cash Flow427.15M319.58M498.13M198.61M-105.10M90.22M
Investing Cash Flow-321.63M-288.64M-291.87M-31.35M-199.81M11.95M
Financing Cash Flow13.72M-106.49M-304.01M-14.05M311.86M-72.13M

Kriti Nutrients Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price78.60
Price Trends
50DMA
68.02
Negative
100DMA
71.82
Negative
200DMA
84.90
Negative
Market Momentum
MACD
-2.30
Negative
RSI
50.17
Neutral
STOCH
46.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KRITINUT, the sentiment is Neutral. The current price of 78.6 is above the 20-day moving average (MA) of 62.09, above the 50-day MA of 68.02, and below the 200-day MA of 84.90, indicating a neutral trend. The MACD of -2.30 indicates Negative momentum. The RSI at 50.17 is Neutral, neither overbought nor oversold. The STOCH value of 46.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:KRITINUT.

Kriti Nutrients Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
₹3.20B9.380.43%16.35%-32.55%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
₹15.73B120.130.06%
58
Neutral
₹7.46B43.5323.11%1930.97%
58
Neutral
₹2.69B14.28-29.77%-60.54%
54
Neutral
₹3.88B11.19-3.96%
45
Neutral
₹1.86B-1.681.70%-71.32%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:KRITINUT
Kriti Nutrients Limited
63.84
-29.67
-31.73%
IN:IFBAGRO
IFB Agro Industries Ltd.
796.00
321.65
67.81%
IN:KOTHARIPRO
Kothari Products Limited.
64.99
-4.21
-6.08%
IN:PASHUPATI
Pashupati Cotspin Ltd.
996.75
339.22
51.59%
IN:SAKHTISUG
Sakthi Sugars Limited
15.65
-6.24
-28.51%
IN:TRF
TRF Limited.
244.00
-97.85
-28.62%

Kriti Nutrients Limited Corporate Events

Kriti Nutrients updates Memorandum of Association after EGM approval
Mar 23, 2026
Kriti Nutrients Limited has notified the stock exchanges that shareholders approved and adopted a revised Memorandum of Association at an Extraordinary General Meeting held on 20 March 2026 in Indore. The amendment includes the insertion of a new ...
Kriti Nutrients Updates Articles of Association After Shareholder Approval
Mar 23, 2026
Kriti Nutrients Limited has notified the stock exchanges that shareholders approved and adopted a new set of Articles of Association at an Extraordinary General Meeting held on 20 March 2026. The changes include the insertion of a new Article 92 a...
Kriti Nutrients Confirms SEBI Dematerialisation Compliance for December Quarter
Jan 10, 2026
Kriti Nutrients Limited has confirmed that, for the quarter ended 31 December 2025, all securities submitted for dematerialisation have been duly processed in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 31, 2026